Chuck Brynelsen

As Senior Vice President of Abbot Vascular, Chuck Brynelsen leads an organization focused upon reducing the global impact of cardiovascular disease. Chuck was previously the Global President of Early Technologies for Medtronic and President of Early Technologies for Covidien. Chuck has also spent seven years as CEO of Intrapace, a start-up medical device company treating obesity. Before Intrapace, Check spent 24 years at Medtronic in various regional, business unit and corporate leadership roles as the company went from a $250 million pacemaker company to a diversified medical technology enterprise with over $10 billion in revenues.